 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

With its stock down 7.9% over the past week, it is easy to disregard Repligen (NASDAQ:RGEN). However, the company's...

Should Weakness in Repligen Corporation's (NASDAQ:RGEN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Repligen Co. (NASDAQ:RGEN  Get Free Report) has been given a consensus rating of Moderate Buy by the nine brokerages that are currently covering the firm, Marketbeat.com reports...

Repligen Co. (NASDAQ:RGEN) Receives $196.70 Average Price Target from Analysts

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax...

Repligen Appoints Maggie A. Pax to Board of Directors

Repligen Co. (NASDAQ:RGEN  Free Report)  Zacks Research dropped their Q1 2024 earnings per share (EPS) estimates for Repligen in a note issued to investors on Wednesday, March 13th...

Zacks Research Brokers Lower Earnings Estimates for Repligen Co. (NASDAQ:RGEN)

Repligen Co. (NASDAQ:RGEN  Free Report)  Research analysts at Zacks Research dropped their Q1 2024 earnings per share estimates for shares of Repligen in a research note issued to...

Repligen Co. (NASDAQ:RGEN) to Post Q1 2024 Earnings of $0.29 Per Share, Zacks Research Forecasts

Repligen Co. (NASDAQ:RGEN  Get Free Report) VP Ralf Kuriyel sold 3,517 shares of the firms stock in a transaction dated Monday, March 11th. The shares were sold at an average price of...

Repligen Co. (NASDAQ:RGEN) VP Sells $681,348.41 in Stock

Comerica Bank grew its position in shares of Repligen Co. (NASDAQ:RGEN  Free Report) by 1,259.1% during the third quarter, according to its most recent Form 13F filing with the Securities...

Comerica Bank Increases Position in Repligen Co. (NASDAQ:RGEN)

Repligen Corp CEO Anthony Hunt Sells 16,707 Shares

Profund Advisors LLC trimmed its holdings in shares of Repligen Co. (NASDAQ:RGEN  Free Report) by 14.0% during the third quarter, according to its most recent 13F filing with the Securities...

Profund Advisors LLC Sells 227 Shares of Repligen Co. (NASDAQ:RGEN)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Volume (M)	702.00
52-Wk High	$211.13
52-Wk Low	$110.45

RGEN Repligen Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals